Codon Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 2

- Investments
- 37
- Portfolio
- 15
- Exits
- 12

Codon Capital General Information
Description
Founded in 2013, Codon Capital is a venture capital firm based in San Francisco, California. The firm acts as both an accelerator and a virtual laboratory to bring together entrepreneurs and researchers to discover strategies for translating innovation into important products and startup companies.
Contact Information
- San Francisco, CA
- United States
Codon Capital Investments (37)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Good( Drug Discovery) | 07-May-2020 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | 0000 0000000000 |
00000 000 | 30-Apr-2020 | 00000 00000 | 00000 | Other Agriculture | Generating Revenue | |
000000 | 09-Jan-2020 | 00000 00000 | 000.00 | Pharmaceuticals | Generating Revenue | 0000 0000000000 |
000000 00000000000 | 23-Dec-2019 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 1 | 0000 0000000000 |
00000000 | 01-Nov-2019 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | 0000 0000000000 |
0000000 0000000000 | 08-Sep-2019 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000 0000000000 |
00000000 | 02-Aug-2019 | 00000 00000 | Biotechnology | Generating Revenue | 0000 0000000000 | |
000000000 00000000 | 07-May-2019 | 00000 00000 | Therapeutic Devices | Generating Revenue | 0000 0000000000 | |
Good( Drug Discovery) | 07-Nov-2018 | Seed Round | Drug Discovery | Generating Revenue | 0000 0000000000 | |
Pivot Bio | 13-Sep-2018 | Later Stage VC | 0000 | Other Agriculture | Generating Revenue | 0000 0000000000 |
Codon Capital Exits (12)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Shattuck Labs | 09-Oct-2020 | IPO | 00000 |
0000000 0000000000 | 12-Jun-2020 | 000 | 00000 |
0000 0000000000000 | 24-Apr-2020 | 000 | 00000 |
0000 000000000000 | 01-Nov-2019 | 000 | 0000 |
0000000 | 07-Dec-2018 | 000 00 00000000 | |
00000 00000000000 | 15-Mar-2018 | 000 | 00000 |
000000 | 13-Feb-2018 | 0000000 000000 | |
00000000 000000000 | 14-Mar-2016 | 000000000000000000 | 0000 |
Glycostasis | 01-Dec-2015 | Merger/Acquisition | |
Kura Oncology | 05-Nov-2015 | Public Investment 2nd Offering | 0000 |
Codon Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Codon Capital‘s full profile, request access.
Request a free trialCodon Capital Investments by Industry, Year, and Region
Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialCodon Capital Team (2)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Karl Handelsman | Founder | 00 | 0 | 0 | San Francisco, CA |
Mitchell Mutz Ph.D | Partner | 0 | 0 | 0 | San Francisco, CA |
Codon Capital Co-Investors (63)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Roche Venture Fund | 3 | 0 |
![]() |
![]() |
|
3x5 Partners | 0 | 0 |
![]() |
![]() |
|
Alexandria Venture Investments | 0 | 0 |
![]() |
![]() |
|
Karl Handelsman | 0 | 0 |
![]() |
![]() |
|
RiverVest Venture Partners | 0 | 0 |
![]() |
![]() |